Mark J. McArthur

9.4k citations

45 papers · 6.9k indexed · 1 hit paper · h-index 26

Molecular Biology top 1%
Oncology top 0.5%
Cancer Research top 1%
Biotechnology top 0.2%
Genetics top 2%

Co-authors: Charles A. Montgomery Michele Harvey Allan Bradley Lawrence A. Donehower Janet S. Butel Betty L. Slagle Ann B. Kier Wallace B. Baze
Topics: Cancer-related Molecular Pathways (8 papers)Virus-based gene therapy research (6 papers)Cancer Research and Treatments (5 papers)
Cited by: Oncology Biotechnology Cancer Research
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: United States Hungary Australia

In The Last Decade

Mark J. McArthur

45 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1992 3.8k citations Lawrence A. Donehower, Michele Harvey et al. Nature profile →

Peers

Countries citing papers authored by Mark J. McArthur

Since Specialization

Citations

This map shows the geographic impact of Mark J. McArthur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. McArthur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. McArthur more than expected).

Fields of papers citing papers by Mark J. McArthur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. McArthur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. McArthur. The network helps show where Mark J. McArthur may publish in the future.

Co-authorship network of co-authors of Mark J. McArthur

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. McArthur. A scholar is included among the top collaborators of Mark J. McArthur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. McArthur. Mark J. McArthur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma 2020 ·Cancer Prevention Research ·(unknown),Taghreed Hirz,Irene Guijarro,Monique B. Nilsson,Marlese A. Pisegna,Alissa Poteete,Hampartsoum B. Barsoumian,Jared J. Fradette,(unknown),Don L. Gibbons,Xiangjun Tian,Jing Wang,Jeffrey N. Myers,Mark J. McArthur,Diana Bell,William N. William,John V. Heymach	25
2	Error-Prone Replication through UV Lesions by DNA Polymerase θ Protects against Skin Cancers 2019 ·Cell ·Jung-Hoon Yoon,Mark J. McArthur,(unknown),(unknown),Maki Wakamiya,Louise Prakash,Satya Prakash	83
3	In vivo imaging of radiopaque resorbable inferior vena cava filter infused with gold nanoparticles 2018 ·PubMed ·Aaron Chen,Yang Qiao,(unknown),Jonathan O. Martinez,Ennio Tasciotti,Megan C. Jacobsen,A Melancon,Mark J. McArthur,(unknown),Steven Y. Huang,Marites P. Melancon,Tian Li,Patrick Lee,(unknown)	8
4	Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA) 2017 ·Molecular Cancer Therapeutics ·Michael J. Wagner,Rahul Mitra,Mark J. McArthur,Wallace B. Baze,(unknown),Sherry Y. Wu,Cristian Rodriguez‐Aguayo,Xinna Zhang,Robert L. Coleman,Gabriel Lopez‐Berestein,Anil K. Sood	101
5	Development of an Electroporation and Nanoparticle-based Therapeutic Platform for Bone Metastases 2017 ·Radiology ·Marites P. Melancon,(unknown),David Fuentes,Tian Li,Yang Qiao,Jianhua Gu,Mihai Gagea,Joe Ensor,Nina M. Muñoz,(unknown),K. Dixon,Amanda McWatters,Jennifer Mitchell,Mark J. McArthur,Sanjay Gupta,Alda L. Tam	19
6	Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer 2016 ·Molecular Cancer Therapeutics ·(unknown),Xian Chen,Tuyen Bui,Yufeng Jiang,Dong Yang,Smruthi Vijayaraghavan,Mark J. McArthur,Kelly K. Hunt,Khandan Keyomarsi	51
7	hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies 2015 ·Cancer Cell ·Miguel Gallardo,Hun Ju Lee,Xiaorui Zhang,Carlos E. Bueso‐Ramos,Laura R. Pageon,Mark J. McArthur,Asha S. Multani,Aziz Nazha,Taghi Manshouri,Jan Parker‐Thornburg,Inmaculada Rapado,Alfonso Quintás‐Cardama,Steven M. Kornblau,Joaquín Martínez‐López,Sean M. Post	110
8	Pilot in vivo study of an absorbable polydioxanone vena cava filter 2015 ·Journal of Vascular Surgery Venous and Lymphatic Disorders ·M. Eggers,Mark J. McArthur,(unknown),Mohamed E. Abdelsalam,(unknown),Laura R. Pageon,Michael B. Wallace,Steven Y. Huang	23
9	Developmental changes in the spatial organization of neurons in the neocortex of humans and common chimpanzees 2013 ·The Journal of Comparative Neurology ·(unknown),Daniel P. Buxhoeveden,Cheryl D. Stimpson,Archibald J. Fobbs,Steven J. Schapiro,Wallace B. Baze,Mark J. McArthur,William D. Hopkins,Patrick R. Hof,Chet C. Sherwood,Katerina Semendeferi	25
10	Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes 2010 ·Cancer Research ·Feng Zhu,Martijn E.T. Dollé,Thomas R. Berton,Raoul Kuiper,(unknown),Alexsandra Espejo,Mark J. McArthur,Mark T. Bedford,Harry van Steeg,Annemieke de Vries,D. Gale Johnson	43
11	Neocortical synaptophysin asymmetry and behavioral lateralization in chimpanzees (Pan troglodytes) 2010 ·European Journal of Neuroscience ·Chet C. Sherwood,Tetyana Duka,Cheryl D. Stimpson,Natalie M. Schenker-Ahmed,(unknown),Steven J. Schapiro,Wallace B. Baze,Mark J. McArthur,Joseph Erwin,Patrick R. Hof,William D. Hopkins	7
12	E2F2 suppresses Myc‐induced proliferation and tumorigenesis 2009 ·Molecular Carcinogenesis ·Raju V. Pusapati,(unknown),Robert J. Rounbehler,Mark J. McArthur,D. Gale Johnson	37
13	Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells 2007 ·Molecular Carcinogenesis ·Aijin Wang,(unknown),Claudio J. Conti,Mark J. McArthur,C. Marcelo Aldaz,Michael C. MacLeod	25
14	E2F3a Stimulates Proliferation, p53-Independent Apoptosis and Carcinogenesis in a Transgenic Mouse Model 2005 ·Cell Cycle ·(unknown),Mark J. McArthur,D. Gale Johnson	41
15	Rotavirus Disease, but Not Infection and Development of Intestinal Histopathological Lesions, Is Age Restricted in Rabbits 1998 ·Virology ·Max Ciarlet,Mark A. Gilger,Christopher Barone,Mark J. McArthur,Mary K. Estes,Margaret E. Conner	37
16	Inhibition of Retinoid Signaling in Transgenic Mice Alters Lipid Processing and Disrupts Epidermal Barrier Function 1997 ·Molecular Endocrinology ·(unknown),Philip W. Wertz,Mark J. McArthur,Sumihisa Imakado,Jackie R. Bickenbach,Dennis R. Roop	33
17	Effects of genetic background on tumorigenesis in p53‐deficient mice 1995 ·Molecular Carcinogenesis ·Lawrence A. Donehower,Michele Harvey,Hannes Vogel,Mark J. McArthur,Charles A. Montgomery,Sang H. Park,Timothy Thompson,R. Ford,Allan Bradley	207
18	Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursbreakdown → 1992 ·Nature ·Lawrence A. Donehower,Michele Harvey,Betty L. Slagle,Mark J. McArthur,Charles A. Montgomery,Janet S. Butel,Allan Bradley	3806
19	The bistratenes: new cytotoxic marine macrolides which induce some properties indicative of differentiation in HL-60 cells 1990 ·Biochemical Pharmacology ·Dianne Watters,(unknown),Susan L. Hamilton,(unknown),Mark J. McArthur,G. J. Seymour,Clifford J. Hawkins,Robert A. Gardiner,Martin F. Lavin	16
20	Fatty acid activation of protein kinase C: Dependence on diacylglycerol 1988 ·Biochemical and Biophysical Research Communications ·(unknown),Mark J. McArthur,Susan L. Hamilton	36

About Mark J. McArthur

Mark J. McArthur is a scholar working on Biotechnology, Internal Medicine and Emergency Medical Services, having authored 45 papers that have together received 6.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Virus-based gene therapy research (6 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Oncology (3.6k citations), Biotechnology (930 citations) and Cancer Research (1.2k citations). Mark J. McArthur has collaborated with scholars based in United States, Hungary and Australia. Frequent co-authors include Charles A. Montgomery, Michele Harvey, Allan Bradley, Lawrence A. Donehower, Janet S. Butel, Betty L. Slagle, Ann B. Kier, Wallace B. Baze, Friedhelm Schroeder and Andrey V. Frolov. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact